These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3667353)
21. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration. Irion R; Gall H; Peter RU Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948 [No Abstract] [Full Text] [Related]
23. Utility of thrombocytopenia as a marker for heparin allergy in adult ED patients. Howell MD; Powers RD Am J Emerg Med; 2006 May; 24(3):268-70. PubMed ID: 16635695 [TBL] [Abstract][Full Text] [Related]
28. [Subcutaneous calcium heparinate: a new heparin]. Desrochers Y Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066 [No Abstract] [Full Text] [Related]
34. Hypereosinophilia and subcutaneous heparin. Giustolisi R; Guglielmo P; di Raimondo F; Cacciola E; Stagno F Lancet; 1993 Nov; 342(8883):1371. PubMed ID: 7901670 [No Abstract] [Full Text] [Related]
35. [A new method of heparin therapy: subcutaneous administration... even in pediatric indications!]. Marosvári I; Nagy Z Orv Hetil; 1989 Jun; 130(25):1359. PubMed ID: 2748154 [No Abstract] [Full Text] [Related]
36. Surreptitious self-administration of heparin. Martin CM; Engstrom PF; Barrett O JAMA; 1970 Apr; 212(3):475-6. PubMed ID: 5467299 [No Abstract] [Full Text] [Related]
37. Factors to consider before discontinuing heparin in patients who develop thrombocytopenia. Shalansky SJ; Verma AK; Levine M Pharmacotherapy; 1999 Aug; 19(8):1011-2. PubMed ID: 10453976 [No Abstract] [Full Text] [Related]
38. Comparison at the clinical level of different types and routes of heparin administration. Bouvier CA Scand J Haematol Suppl; 1980; 36():91-100. PubMed ID: 6935764 [No Abstract] [Full Text] [Related]